{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"10","upperLimit":"11","value":"11"},{"groupId":"OG001","lowerLimit":"11","upperLimit":"11","value":"11"}]}],"title":"ANC"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"11","upperLimit":"14","value":"13"},{"groupId":"OG001","lowerLimit":"11","upperLimit":"15","value":"13"}]}],"title":"Platelet"}],"denoms":[{"counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"48"}],"units":"Participants"}],"description":"Comparison of Engraftment Kinetics (absolute neutrophil count (ANC), absolute lymphocyte count (ALC), platelet) between FRE carriers and FRE non-carriers","dispersionType":"Full Range","groups":[{"description":"FRE Negative Participants","id":"OG000","title":"FRE Negative"},{"description":"FRE Positive Participants","id":"OG001","title":"FRE Positive"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Duration between Apheresis Consultation and Day +100","title":"Comparison of Engraftment Kinetics Between FRE Carriers and FRE Non-carriers","type":"SECONDARY","unitOfMeasure":"Engraftment (Days)"}